Volitionrx (VNRX) Cash & Current Investments (2011 - 2026)
Volitionrx's (VNRX) quarterly Cash & Current Investments came in at $1.1 million in Q4 2025, down 65.78% YoY from $3.3 million in Q4 2024, and up 460.17% on a QoQ basis from $199407.0 in Q3 2025.
Volitionrx (VNRX) Cash & Current Investments (2011 - 2026) Analysis & Trends
Volitionrx (VNRX) has 11 years of Cash & Current Investments data on file, last reported at $1.1 million in Q4 2025.
- Quarterly Cash & Current Investments fell 65.78% year-over-year to $1.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.1 million (down 65.78% YoY) and the FY2025 annual result came in at $1.1 million, down 65.78% from the prior year.
- Cash & Current Investments grew to $1.1 million in Q4 2025, from $199407.0 in the prior quarter.
- In the past five years, Cash & Current Investments ranged from a high of $33.1 million in Q1 2021 to a low of $199407.0 in Q3 2025.
- A 5-year average of $12.6 million and a median of $10.8 million in 2022 frame the typical range for Cash & Current Investments.
- Annual changes were most pronounced in 2023 — Cash & Current Investments surged 559.07% — and 2025, when it sank 96.32%.
- Tracing VNRX's Cash & Current Investments over 5 years: stood at $20.6 million in 2021, then sank by 47.2% to $10.9 million in 2022, then surged by 90.76% to $20.7 million in 2023, then slumped by 84.25% to $3.3 million in 2024, then slumped by 65.78% to $1.1 million in 2025.
- The last three Cash & Current Investments figures came in at $1.1 million (Q4 2025), $199407.0 (Q3 2025), and $2.3 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.81 Bn | 193.21 Bn | 7.27 Bn | 5.60 Bn |
| 2 | Stryker | 127.76 Bn | 124.28 Bn | 4.50 Bn | 3.48 Bn |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn | 9.22 Bn |
| 4 | Boston Scientific | 73.25 Bn | 72.71 Bn | 3.85 Bn | 539.00 Mn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 4.25 Bn |
| 6 | Dexcom | 34.43 Bn | 32.49 Bn | 830.00 Mn | 1.95 Bn |
| 7 | GE HealthCare Technologies | 33.88 Bn | 31.77 Bn | 2.18 Bn | 2.11 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 3.32 Bn |
| 9 | Steris | 23.11 Bn | 22.63 Bn | 684.20 Mn | 482.30 Mn |
| 10 | Volitionrx | 1.22 Mn | -1.58 Mn | - | 2.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.79 Mn |
| Dec 31, 2025 | 1.12 Mn |
| Sep 30, 2025 | 199,407.00 |
| Jun 30, 2025 | 2.26 Mn |
| Mar 31, 2025 | 2.60 Mn |
| Dec 31, 2024 | 3.26 Mn |
| Sep 30, 2024 | 5.41 Mn |
| Jun 30, 2024 | 6.00 Mn |
| Mar 31, 2024 | 11.77 Mn |
| Dec 31, 2023 | 20.73 Mn |
| Sep 30, 2023 | 10.81 Mn |
| Jun 30, 2023 | 19.74 Mn |
| Mar 31, 2023 | 10.01 Mn |
| Dec 31, 2022 | 10.87 Mn |
| Sep 30, 2022 | 1.64 Mn |
| Jun 30, 2022 | 16.70 Mn |
| Mar 31, 2022 | 23.73 Mn |
| Dec 31, 2021 | 20.58 Mn |
| Sep 30, 2021 | 22.90 Mn |
| Jun 30, 2021 | 27.91 Mn |